Merck and Google Cloud announce $1 billion AI partnership to transform drug development
6 Sources
[1]
Merck to partner with Google Cloud on AI initiatives
NEW YORK, April 22 (Reuters) - Drugmaker Merck & Co (MRK.N), opens new tab said on Wednesday it will partner with Google Cloud to build up its artificial intelligence capabilities, investing as much as $1 billion with Google over a number of years to fund AI infrastructure, engineers and licensing
[2]
Merck to partner with Google Cloud on AI initiatives
Drugmaker Merck & Co is joining forces with Google Cloud. They will invest up to one billion dollars over several years. This partnership aims to boost Merck's artificial intelligence capabilities. The collaboration will focus on AI infrastructure, engineers, and Google's Gemini Enterprise
[3]
Merck and Google Cloud Launch Up to $1 Billion AI Partnership
Merck has expanded its artificial intelligence strategy through a multi-year partnership with Google Cloud that could reach up to $1 billion over several years. The agreement will support AI infrastructure, software licensing, and engineering collaboration, with Gemini Enterprise set to play a
[4]
Merck to partner with Google Cloud on AI initiatives
NEW YORK, April 22 (Reuters) - Drugmaker Merck & Co said on Wednesday it will partner with Google Cloud to build up its artificial intelligence capabilities, investing as much as $1 billion with Google over a number of years to fund AI infrastructure, engineers and licensing of the tech company's
[5]
Merck partners with Google Cloud in $1 billion AI deal By Investing.com
LAS VEGAS - Merck (NYSE:MRK) and Google Cloud announced today a multi-year partnership valued at up to $1 billion to deploy artificial intelligence technology across the pharmaceutical company's operations, according to a press release statement. The $278 billion pharmaceutical giant's stock has
[6]
Merck to partner with Google Cloud on AI initiatives
NEW YORK, April 22 (Reuters) - Drugmaker Merck & Co said on Wednesday it will partner with Google Cloud to build up its artificial intelligence capabilities, investing as much as $1 billion with Google over a number of years to fund AI infrastructure, engineers and licensing of the tech company's
Share
Copy Link
Pharmaceutical giant Merck has announced a multi-year AI partnership with Google Cloud worth up to $1 billion. The collaboration will deploy Google's Gemini Enterprise platform across Merck's drug research, manufacturing, and regulatory operations. Merck has already cut reimbursement dossier preparation time and costs by half using Google's AI technology, and executives expect the partnership to last at least a decade.
Merck Google Cloud Partnership Marks Major Investment in AI Infrastructure
Pharmaceutical company Merck & Co has committed up to $1 billion over several years in an AI partnership with Google Cloud, marking one of the industry's most substantial investments in artificial intelligence capabilities
1
. The agreement, announced at Google Cloud Next in Las Vegas on April 22, will fund AI infrastructure, engineers, and licensing of the Gemini Enterprise platform to transform operations across Merck's global organization of approximately 75,000 employees3
.
Source: Analytics Insight
Dave Williams, Merck's chief information and digital officer, emphasized that the $1 billion AI deal represents more than a simple technology purchase. "We're not just buying tokens. It is really the tool set" Google Cloud offers, he explained, including access to Gemini Enterprise and the company's engineers who will work directly alongside Merck teams
2
. Williams expects the collaboration to extend for at least a decade, though the companies haven't defined a specific timeframe4
.Deploying AI Across Drug Research and Development Operations
The partnership will deploy artificial intelligence across Merck's drug research, regulatory work, manufacturing, and commercial operations to accelerate drug development
1
. Merck plans to use AI throughout the drug development process, including running computerized simulations of laboratory experiments and expediting regulatory submissions2
. The drugmaker has already been using AI to prepare sections of clinical study reports for roughly two years with measurable success and now intends to expand that approach across more workflows4
.
Source: Market Screener
Thomas Kurian, CEO of Google Cloud, framed the collaboration as technology serving a higher purpose in society. "We've always said we wanted AI to play a positive role in society. One of the ways is to help people find cures to illnesses," Kurian stated. "They have the domain knowledge. We're bringing the AI tools and platform and cyber capability to help them build using these tools"
1
. The partnership represents what Kurian described as "a fundamental shift in how technology supports the entire pharma value chain"5
.
Source: ET
Related Stories
Proven Results in Streamlining Manufacturing Operations and Regulatory Processes
Merck has already demonstrated tangible benefits from using Google's technology to enhance artificial intelligence capabilities in specific workflows. Williams revealed that the company has cut down by half the time and cost of compiling dossiers required in many countries to secure reimbursement for new medicines
1
. Significantly, Williams stressed that "this isn't a pilot"—Merck is actively submitting dossiers in markets using this new capability and scaling it globally4
.The partnership builds on existing work between the companies and will implement the Gemini Enterprise platform across research and development workflows, apply predictive analytics to streamline manufacturing operations, and deploy AI-powered automation in corporate functions
5
. The collaboration aims to digitize more data and integrate AI agents and generative tools into workflows spanning drug discovery, manufacturing optimization, and commercial operations3
. Williams characterized the effort as addressing "a tremendous opportunity" and "a huge information challenge" facing the pharmaceutical industry2
. The timing coincides with what Merck described as a major product launch period for the company, suggesting the AI infrastructure will support critical business objectives in the near term3
.References
Summarized by
Navi
[3]
Related Stories
KPMG Invests $100 Million in Google Cloud Partnership to Accelerate Enterprise AI Adoption
21 Nov 2024•Business and Economy
Google launches $750 million fund to help consulting firms deploy AI agents at enterprise scale
22 Apr 2026•Business and Economy
Salesforce and Google Cloud Forge $2.5 Billion AI Partnership, Reshaping Enterprise Cloud and AI Landscape
25 Feb 2025•Business and Economy
Recent Highlights
1
AI Leaders Warn UN Security Council of Existential Risks, Call for Global AI Governance
Policy and Regulation
2
OpenAI AI Agent Breaches Australian Government Healthcare Portal in Historic Hack
Technology
3
Bill Gates Warns AI Could Cause a Billion Deaths, Calls for Urgent Government Regulation
Policy and Regulation
Recent Highlights
Today's Top Stories
Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Follow topics that matter to you and stay ahead.
